// App-Quantinova.ai

3546 : DNA-damaging reagent -0404 effectively inhibits hepatocellular carcinoma through p53-dependent autophagy

Researchers

Presenter

  • Min Zheng

Principal Investigators

  • Bingjue Ye

  • Guohua Lou

  • Caixia Xia

  • Weiyang Zheng

  • Yanning Yanning

  • Xiao Xu

  • Yongchao Zhao

  • Long Mao

  • Wanghong Xu

Medical Centers

  • Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases. State Key Labor, Hangzhou, China

  • Hangzhou ACEA Pharmaceutical Research Co., Ltd., Hangzhou, China

  • Institute of Translation Medicine, Zhejiang University, Hangzhou, China.

Locations

  • China

Companies

  • Hangzhou ACEA Pharma

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Liver cancer

  • Solid malignancies

Biomarkers

  • Nucleoside diphosphate kinase A

  • Phosphorylated-mechanistic target of rapamycin

  • Sequestosome-1

Drug/Treatment

  • Rapacan

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved